Receive daily AI-curated summaries of engineering articles from top tech companies worldwide.
Endigest AI Core Summary
Researchers at the University of Edinburgh use AI system Co-Scientist to accelerate discovery of treatments for complex liver disease.
•MASH (metabolic dysfunction-associated steatohepatitis) involves interconnected biological processes, making combination therapies necessary rather than single-target drugs.
•Co-Scientist synthesizes evidence across liver biology and pharmacology to identify overlooked connections and narrow candidate drug combinations.
•The system identified why resmetirom, a MASH treatment, only helps a subset of patients by hypothesizing NLRP3 inflammasome as the key molecular link.
•NLRP3 inflammasome couples inflammation and metabolism in MASH—a connection never previously unified into a single actionable explanation.
•
The experimentally-verified hypothesis enables targeted dual-therapies development.
This summary was automatically generated by AI based on the original article and may not be fully accurate.
Deepmind
Google Cloud